Busca ao vivo
O TopFind está buscando as correspondências mais recentes para a sua pesquisa.
Analisamos 6 resultados ao vivo para herzuma e reduzimos para 3 opções que parecem valer mais a comparação primeiro.
Os temas mais fortes nesta lista curta são Oncology e Biosimilar.
Fonte: Celltrion Healthcare Singapore Private Limited
Descrição
Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies.
Melhor para
HER2 Positive cancer care, Breast cancer patients e Affordable trastuzumab access
Avaliação
Fonte: Celltrion Healthcare Philippines Inc.
Descrição
Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics.
Melhor para
HER2 Positive cancer, Oncology therapy e Biosimilar oncology
Avaliação
Fonte: Celltrion Healthcare
Descrição
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
Melhor para
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy e Oncology infusion treatment
Avaliação
| Comparar | Herzuma | Herzuma (Trastuzumab) | Herzuma (Trastuzumab) |
|---|---|---|---|
| Fonte | Celltrion Healthcare Singapore Private Limited | Celltrion Healthcare Philippines Inc. | Celltrion Healthcare |
| Descrição | Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies. | Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. |
| Melhor para | HER2 Positive cancer care, Breast cancer patients e Affordable trastuzumab access | HER2 Positive cancer, Oncology therapy e Biosimilar oncology | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy e Oncology infusion treatment |
| Ação | |||
| Avaliação |
Se você quer começar pela opção mais equilibrada, eu recomendo:
"Herzuma de Celltrion Healthcare Singapore Private Limited."
Eu escolhi isso porque Herzuma is a subsidy-eligible trastuzumab biosimilar that ensures affordability and accessibility for breast and gastric cancer patients in Singapore.